UiPath (NYSE: PATH) CEO sells 1.4M shares, still holds 26,491,238

Rhea-AI Filing Summary

UiPath, Inc. (PATH) reported that CEO, Chairman and major shareholder Daniel Dines sold 1,402,347 shares of Class A Common Stock on 2026-08-19 at a weighted-average price of about $16.07 per share. The sale was made pursuant to a pre-arranged Rule 10b5-1 qualified selling plan. Following this transaction, Dines directly holds 26,491,238 shares of UiPath Class A Common Stock.

Insider Trade Summary 10b5-1

Net Seller: 1,402,347 shares

Net Sell 1 txn

Insider Dines Daniel

Role CEO and Chairman

Sold 1,402,347 shs ($22.54M)

Type	Security	Shares	Price	Value
Sale	Class A Commmon Stock F1, F2	1,402,347	$16.0726	$22.54M

Holdings After Transaction: Class A Commmon Stock — 26,491,238 shares (Direct)

Footnotes (2)

1. F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
2. F2. The range of prices for the transactions reported was from $16.0000 to $16.1600. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Key Figures

Shares sold: 1,402,347 shares Average sale price: $16.0726 per share Post-transaction holdings: 26,491,238 shares +3 more

6 metrics

Shares sold 1,402,347 shares Class A Common Stock sold by Daniel Dines on 2026-08-19

Average sale price $16.0726 per share Weighted-average price for the reported sale transactions

Post-transaction holdings 26,491,238 shares Class A Common Stock directly held by Daniel Dines after the sale

Price range $16.0000 to $16.1600 per share Range of prices for the reported transactions

Net shares sold 1,402,347 shares Net sell volume across all reported transactions in this filing

Transaction count 1 sale Number of non-derivative sale transactions reported

Key Terms

Rule 10b5-1, qualified selling plan, Class A Commmon Stock, Securities Exchange Act of 1934

4 terms

Rule 10b5-1 regulatory

"adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

qualified selling plan financial

"These shares were sold in compliance with a qualified selling plan adopted"

Class A Commmon Stock financial

"security_title": "Class A Commmon Stock""

Securities Exchange Act of 1934 regulatory

"pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934"

FAQ

What insider transaction did PATH report for CEO Daniel Dines?

UiPath (PATH) reported that CEO Daniel Dines sold 1,402,347 Class A shares on 2026-08-19. The shares were sold at an average price of about $16.07 under a pre-arranged Rule 10b5-1 selling plan.

At what price did Daniel Dines sell UiPath (PATH) shares?

Daniel Dines sold UiPath (PATH) shares at a weighted-average price of about $16.07 per share. The filing notes an actual trade price range between $16.00 and $16.16 for the reported transactions.

How many UiPath (PATH) shares did Daniel Dines sell and when?

Daniel Dines sold 1,402,347 shares of UiPath (PATH) Class A Common Stock on 2026-08-19. The transaction was reported as an open-market or private sale under SEC transaction code S.

How many UiPath (PATH) shares does Daniel Dines own after this sale?

After the reported sale, Daniel Dines directly holds 26,491,238 shares of UiPath (PATH) Class A Common Stock. This post-transaction holding reflects only the position disclosed in this specific insider filing.

Was the UiPath (PATH) insider sale by Daniel Dines under a Rule 10b5-1 plan?

Yes. The filing states the 1,402,347-share sale by Daniel Dines was executed under a qualified selling plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.

What price range did the UiPath (PATH) trades by Daniel Dines cover?

The Form 4 discloses that the transactions occurred within a price range of $16.00 to $16.16 per share. The reporting person has undertaken to provide full breakdowns by specific price upon request to regulators or security holders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/19/2026 - 08:28 PM Accepted by SEC EDGAR 08/19/2026 - 08:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Commmon Stock	08/19/2026		S		1,402,347(1)	D	$16.0726(2)	26,491,238	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $16.0000 to $16.1600. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)